6-33697637-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_032340.4(UQCC2):c.*16C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000626 in 1,586,150 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0031 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 5 hom. )
Consequence
UQCC2
NM_032340.4 3_prime_UTR
NM_032340.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.63
Genes affected
UQCC2 (HGNC:21237): (ubiquinol-cytochrome c reductase complex assembly factor 2) This gene encodes a nucleoid protein localized to the mitochondria inner membrane. The encoded protein affects regulation of insulin secretion, mitochondrial ATP production, and myogenesis through modulation of mitochondrial respiratory chain activity. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 6-33697637-G-A is Benign according to our data. Variant chr6-33697637-G-A is described in ClinVar as [Benign]. Clinvar id is 387464.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UQCC2 | NM_032340.4 | c.*16C>T | 3_prime_UTR_variant | 4/4 | ENST00000607484.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UQCC2 | ENST00000607484.6 | c.*16C>T | 3_prime_UTR_variant | 4/4 | 1 | NM_032340.4 | P1 | ||
UQCC2 | ENST00000374214.3 | c.*16C>T | 3_prime_UTR_variant | 3/3 | 5 | ||||
UQCC2 | ENST00000374231.8 | c.*16C>T | 3_prime_UTR_variant | 4/5 | 3 | ||||
UQCC2 | ENST00000606961.1 | n.1021C>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.00307 AC: 468AN: 152218Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
468
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000884 AC: 211AN: 238754Hom.: 3 AF XY: 0.000718 AC XY: 93AN XY: 129518
GnomAD3 exomes
AF:
AC:
211
AN:
238754
Hom.:
AF XY:
AC XY:
93
AN XY:
129518
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000365 AC: 524AN: 1433814Hom.: 5 Cov.: 28 AF XY: 0.000334 AC XY: 239AN XY: 714694
GnomAD4 exome
AF:
AC:
524
AN:
1433814
Hom.:
Cov.:
28
AF XY:
AC XY:
239
AN XY:
714694
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00308 AC: 469AN: 152336Hom.: 1 Cov.: 33 AF XY: 0.00286 AC XY: 213AN XY: 74504
GnomAD4 genome
AF:
AC:
469
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
213
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 11, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at